FDA Inspection 1232033 — Visum Pharmaceutical Co Ltd

Visum Pharmaceutical Co Ltd — FEI 3009283401

The FDA completed an inspection of Visum Pharmaceutical Co Ltd on Dec 13, 2023 in Haikou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 13, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Haikou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.